Clifford Riley King,David William Bristol,Michael L. English
申请号：
US13723323
公开号：
US08883863B1
申请日:
2012.12.21
申请国别(地区):
US
年份:
2014
代理人:
摘要：
A pharmaceutical drug product with at least one drug substance capable of providing immediate release or modified release profiles. The drug substance is selected from an amorphous form with an active pharmaceutical ingredient and a first organic counterion wherein the amorphous form has a phase transition temperature of at least 100° C. and a morphological form with the active pharmaceutical ingredient and a second organic counterion wherein the morphological form of the drug substance has a phase transition temperature of at least 100° C.
